DermTech, Inc.DermTech, Inc.DermTech, Inc.

DermTech, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪14.68 M‬USD
−2.6856USD
‪−100.89 M‬USD
‪15.30 M‬USD
‪31.88 M‬
Beta (1Y)
2.06

About DermTech, Inc.

CEO
Bret Christensen
Headquarters
San Diego
Employees (FY)
208
Founded
1995
FIGI
BBG00H19F184
DermTech, Inc. engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate diagnosis and management of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. Its products and services include melanoma test, smart sticker, and telemedicine option for melanoma test. The company was founded in 1995 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of DMTK is 0.4200 USD — it has increased by 18.31% in the past 24 hours. Watch DermTech, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange DermTech, Inc. stocks are traded under the ticker DMTK.
DMTK stock has fallen by 29.41% compared to the previous week, the month change is a 32.86% fall, over the last year DermTech, Inc. has showed a 81.74% decrease.
We've gathered analysts' opinions on DermTech, Inc. future price: according to them, DMTK price has a max estimate of 4.00 USD and a min estimate of 0.63 USD. Watch DMTK chart and read a more detailed DermTech, Inc. stock forecast: see what analysts think of DermTech, Inc. and suggest that you do with its stocks.
DMTK reached its all-time high on Feb 22, 2021 with the price of 84.4900 USD, and its all-time low was 0.4884 USD and was reached on May 17, 2024. View more price dynamics on DMTK chart.
See other stocks reaching their highest and lowest prices.
DMTK stock is 57.87% volatile and has beta coefficient of 2.06. Track DermTech, Inc. stock price on the chart and check out the list of the most volatile stocks — is DermTech, Inc. there?
Today DermTech, Inc. has the market capitalization of ‪14.68 M‬, it has increased by 5.71% over the last week.
Yes, you can track DermTech, Inc. financials in yearly and quarterly reports right on TradingView.
DermTech, Inc. is going to release the next earnings report on Aug 6, 2024. Keep track of upcoming events with our Earnings Calendar.
DMTK earnings for the last quarter are −0.50 USD per share, whereas the estimation was −0.57 USD resulting in a 12.51% surprise. The estimated earnings for the next quarter are −0.52 USD per share. See more details about DermTech, Inc. earnings.
DermTech, Inc. revenue for the last quarter amounts to ‪3.85 M‬ USD despite the estimated figure of ‪3.94 M‬ USD. In the next quarter revenue is expected to reach ‪4.14 M‬ USD.
DMTK net income for the last quarter is ‪−20.01 M‬ USD, while the quarter before that showed ‪−19.09 M‬ USD of net income which accounts for −4.81% change. Track more DermTech, Inc. financial stats to get the full picture.
No, DMTK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 23, 2024, the company has 208.00 employees. See our rating of the largest employees — is DermTech, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DermTech, Inc. EBITDA is ‪−85.32 M‬ USD, and current EBITDA margin is −639.99%. See more stats in DermTech, Inc. financial statements.
Like other stocks, DMTK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DermTech, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DermTech, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DermTech, Inc. stock shows the sell signal. See more of DermTech, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.